The interaction of liposomes with the complement system: In vitro and in vivo assays

Methods in Enzymology

Volumn 373, Issue , 2003, Pages 136-154

  Szebeni, Janos ^a   Baranyi, Lajos ^a   Savay, Sandor ^a   Milosevits, Janos ^a   Bodo, Michael ^a   Bunger, Rolf ^a   Alving, Carl R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; IMMUNOLOGICAL ADJUVANT; LIPOSOME; DRUG CARRIER; VACCINE;

ANIMAL; ARTICLE; BIOASSAY; BLOOD PRESSURE; DRUG EFFECT; HUMAN; IMMUNOLOGY; METHODOLOGY; PHYSIOLOGY; RAT; SWINE; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNITY; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOLOGICAL ASSAY; BLOOD PRESSURE; COMPLEMENT SYSTEM PROTEINS; HUMANS; LIPOSOMES; RATS; SWINE;

EID: 1342269093     PISSN: 00766879     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0076-6879(03)73010-9     Document Type: Article

References (35)

1. C. R. Alving, Ann. N. Y. Acad. Sci. 754, 143 (1995).
2. C. R. Alving, V. Koulchin, G. M. Glenn and M. Rao, Immunol. Rev. 145, 5 (1995).
3. H. M. Patel, Crit. Rev. Ther. Drug Carrier Syst. 9, 39 (1992).
4. N. Van Rooijen and A. Sanders, J. Immunol. Methods 174, 83 (1994).
5. N. van Rooijen, J. Bakker and A. Sanders, Trends Biotechnol. 15, 178 (1997).
6. M. Rao and C. R. Alving, Adv. Drug Deliv. Rev. 41, 171 (2000).
7. M. Rao, S. W. Rothwell, and C. R. Alving, Methods Enzymol. 373, 16 (2003).
8. J. A. Haxby, C. B. Kinsky and S. C. Kinsky, Proc. Natl. Acad. Sci. USA 61, 300 (1968).
9. J. A. Haxby, O. Gotze, H. J. Muller-Eberhard, and S. C. Kinsky, Proc. Natl. Acad. Sci. USA 64, 290 (1969).
10. S. C. Kinsky, J. A. Haxby, D. A. Zopf, C. R. Alving, and C. B. Kinsky, Biochemistry 8(10), 4149 (1969).
11. C. R. Alving, S. C. Kinsky, J. A. Haxby, and C. B. Kinsky, Biochemistry 8, 1582 (1969).
12. A. J. Bradley, D. V. Devine, S. M. Ansell, J. Janzen and D. E. Brooks, Arch. Biochem. Biophys. 357, 185 (1998).
13. J. Szebeni, Crit. Rev. Ther. Drug Carrier Syst. 15(1), 57 (1998).
14. J. Szebeni, Crit. Rev. Ther. Drug Carr. Syst. 18, 567 (2001).
15. Rother, K., Ed., "The Complement System," Springer Verlag, 1998.
16. J. D. Lambris, and U. M. Holers, Eds., "Therapeutic Interventions in the Complement System," Humana Press, 2000.
17. J. Bernard and M. J. Morley, Eds. "The Complement Factsbook," Walport Paperback, 2000.
18. J. Szebeni, J. L. Fontana, N. M. Wassef, P. D. Mongan, D. S. Morse, D. E. Dobbins, G. L. Stahl, R. Bünger, and C. R. Alving, Circulation 99, 2302 (1999).
19. J. Szebeni, B. Baranyi, S. Savay, M. Bodo, D. S. Morse, M. Basta, G. L. Stahl, R. Bunger, and C. R. Alving, Am. J. Physiol. 279, H1319 (2000).
20. J. Szebeni, N. M. Wassef, H. Spielberg, A. S. Rudolph, and C. R. Alving, Biochem. Biophys. Res. Comm. 205, 255 (1994).
21. J. Szebeni, N. M. Wassef, A. S. Rudolph, and C. R. Alving, Biochim. Biophys. Acta 1285, 127 (1996).
22. J. Szebeni, N. M. Wassef, K. R. Hartman, A. S. Rudolph, and C. R. Alving, Transfusion 37, 150 (1997).
23. J. Szebeni, H. Spielberg, R. O. Cliff, N. M. Wassef, A. S. Rudolph, and C. R. Alving, Art. Cells Blood Subs. Immob. Biotechnol. 25, 379 (1997).
24. J. Szebeni, B. Baranyi, S. Savay, L. U. Lutz, E. Jelezarova, R. Bunger, and C. R. Alving, J. Liposome Res. 10, 347 (2000).
25. C. R. Alving, R. L. Richards, and A. A. Guirguis, J. Immunol. 118, 342 (1977).
26. C. R. Alving, K. A. Urban, and R. L. Richards, Biochim. Biophys. Acta, 600, 117 (1980).
27. S. Shichijo, G. Toffano, and C. R. Alving, J. Immunol. Methods 85, 53 (1985).
28. R. L. Richards, R. C. Habbersett, I. Scher, A. S. Janoff, H. P. Schieren, L. D. Mayer, P. R. Cullis, and C. R. Alving, Biochim. Biophys. Acta 855(2), 223 (1986).
29. D. Labarre, B. Montdargent, M.-P. Carreno, and F. Maillet, J. Appl. Biomat. 4, 231 (1993).
30. A. G. Osler, J. H. Strauss, and M. M. Mayer, Am. J. Syph. Gonorrhea Vener. Dis. 36, 140 (1952).
31. M. M. Mayer, Complement and complement fixation, in "Kabat and Mayer's Experimental Immunochemistry," 2nd ed., E. A. Kabat and M. M. Mayer Eds., p. 133, Springfield, IL, Charles C. Thomas, 1961.
32. C. Plank, M. X. Tang, A. R. Wolfe, and F. C. Szoka, Hum. Gene Ther. 10, 319 (1999).
33. P. H. Pfeifer, M. S. Kawahara, and T. E. Hugli, Clin. Chem. 45, 1190 (1999).
34. J. Szebeni, C. R. Alving, S. Savay, Y. Barenholz, A. Priev, D. Danino, and Y. Talmon, Intern. 1, 721 (2001).
35. A. Chanan-Khan, J. Szebeni, S. Savay, L. Liebes, N. M. Rafigue, C. R. Alving, F. M. Muggia, Ann. Oncol. 14, 1430 (2003).